The Cancer Institute NSW Research Equipment Grant (REG) ensures that the state has world class infrastructure to accelerate cancer research and realise clinical benefits.
June 2025
What was approved
Approved for University of Newcastle
$599,132 was approved by
Cancer Institute NSW Chief ExecutiveDate approved
June 2025Location of the recipient
NewcastleAbout the grant
Applications approved
3
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
Five years. Equipment must be acquired by 31 July 2026What was approved
Approved for University of Sydney
$600,000 was approved by
Cancer Institute NSW Chief ExecutiveDate approved
June 2025Location of the recipient
SydneyAbout the grant
Applications approved
3
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
Five years. Equipment must be acquired by 31 July 2026What was approved
Approved for University of Sydney
$600,000 was approved by
Cancer Institute NSW Chief ExecutiveDate approved
June 2025Location of the recipient
Western SydneyAbout the grant
Applications approved
3
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
Five years. Equipment must be acquired by 31 July 2026June 2024
What was approved
Approved for Garvan Institute of Medical Research
Akoya-PhenoCycler Fusion imaging platform for ground truth spatial assessment of distinct cancer niches and tumour ecosystems
$695,160 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
June 2024Location of the recipient
Darlinghurst 2010About the grant
Applications approved
2
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
5 yearsWhat was approved
Approved for University of Sydney
Translating cancer research to clinical use: Phenolmager HT 2.0 to enable high throughput, low-cost spatial biology data to bridge research to clinical use. A versatile system for rapid whol slide imaging of phenotypes to signatures, empowering precision medicine in cancer cell analysis.
$674,927 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
June 2024Location of the recipient
Camperdown 2050About the grant
Applications approved
2
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
5 yearsMay 2023
What was approved
Approved for Garvan Institute of Medical Research
$889,048 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
May 2023Location of the recipient
Darlinghurst 2010About the grant
Applications approved
1
Applications received
6
Targeted Research Equipment Grant
Agency funding this grant
Cancer Institute NSWProgram term
5 years